Thomas Zindrick
Chief Executive Officer at GENELUX CORPORATION
Net worth: 48 641 $ as of 2024-04-29
Thomas Zindrick active positions
Companies | Position | Start | End |
---|---|---|---|
GENELUX CORPORATION | Chairman | 2023-03-31 | - |
Chief Executive Officer | 2014-05-27 | - | |
President | 2014-05-27 | - | |
Director/Board Member | 2014-05-27 | - | |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Director/Board Member | 2018-08-15 | - |
Career history of Thomas Zindrick
Former positions of Thomas Zindrick
Companies | Position | Start | End |
---|---|---|---|
Amitech Therapeutic Solutions, Inc | Director/Board Member | 2010-12-31 | 2021-01-31 |
Chief Executive Officer | 2011-12-31 | 2021-01-31 | |
DNX Biopharmaceuticals, Inc.
DNX Biopharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services DNX Biopharmaceuticals, Inc. operates as a biopharmaceuticals company. It develops long-acting therapeutic proteins for the treatment of patients with life-long diseases. The company was founded by John Caputo, Rajiv Datar, and Howard Levine in 2014 and is headquartered in Irvine, CA. | Director/Board Member | 2014-10-31 | 2020-02-29 |
AMGEN INC. | Compliance Officer | 2003-12-31 | 2007-12-31 |
Corporate Officer/Principal | 2000-12-31 | 2008-12-31 | |
DOW CHEMICAL COMPANY (THE) | Corporate Officer/Principal | - | - |
Training of Thomas Zindrick
North Central College | Undergraduate Degree |
University of Illinois College of Law | Graduate Degree |
Statistics
International
United States | 9 |
Operational
Director/Board Member | 4 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
AMGEN INC. | Health Technology |
GENELUX CORPORATION | Health Technology |
Private companies | 4 |
---|---|
The Dow Chemical Co.
The Dow Chemical Co. Chemicals: SpecialtyProcess Industries The Dow Chemical Co. engages in the manufacture and distribution of chemicals, plastics, industrial and agricultural products. It serves agriculture, automotive, building and construction, consumer, electronic materials, infrastructure, packaging, product finder and product safety industries. The company was founded by Herbert Henry Dow in 1897 and is headquartered in Midland, MI. | Process Industries |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Health Technology |
DNX Biopharmaceuticals, Inc.
DNX Biopharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services DNX Biopharmaceuticals, Inc. operates as a biopharmaceuticals company. It develops long-acting therapeutic proteins for the treatment of patients with life-long diseases. The company was founded by John Caputo, Rajiv Datar, and Howard Levine in 2014 and is headquartered in Irvine, CA. | Commercial Services |
Amitech Therapeutic Solutions, Inc |
- Stock Market
- Insiders
- Thomas Zindrick
- Experience